Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation and complement activation.

K Christensen1, R Larsson, H Emanuelsson

  • 1Division of Cardiology, Medical Center Hospital, Orebro, Sweden.

Biomaterials
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term clinical outcome in patients with glutathione synthetase deficiency.

The Journal of pediatrics·2001
Same author

The pressure at the lower inflexion point has no relation to airway collapse in surfactant-treated premature lambs.

Acta anaesthesiologica Scandinavica·2001
Same author

Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.

Anticancer research·2001
Same author

Is it necessary to order aspartate aminotransferase with alanine aminotransferase in clinical practice?

Clinical chemistry·2001
Same author

Angiogenesis and angiogenic growth factors in Wilms tumor.

The Journal of urology·2001
Same author

An open and flexible framework for computer aided surgical training.

Studies in health technology and informatics·2001
Same journal

A dual-engineered chondrocyte-targeting tetrahedral DNA-based nanoparticle for improved delivery of metformin and alleviation in osteoarthritis.

Biomaterials·2026
Same journal

Machine learning-guided design of cooperative multi-size hydrogel microspheres for osteoarthritis therapy.

Biomaterials·2026
Same journal

Cationic nanotrap curbs UVB-induced cutaneous photodamage via exosomal cfNA capture.

Biomaterials·2026
Same journal

A protein-initiated polymerization cascade enables a self-eliminating powder tissue adhesive for diabetic ulcer repair.

Biomaterials·2026
Same journal

Oral colon-targeted micro-nano formulation engineered in microfluid for synergistic therapy of inflammatory bowel disease.

Biomaterials·2026
Same journal

Manganese@Gold cluster-coordinated covalent organic frameworks-based artificial metalloenzymes with cascade biocatalysis and amplified systemic stimulation to combat malignant tumor metastasis.

Biomaterials·2026
See all related articles

Heparin coating of new stent grafts significantly improved blood compatibility by reducing platelet activation and coagulation. This innovative stent design minimizes thrombotic material deposition, enhancing safety for medical applications.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Engineering
  • Hematology

Background:

  • Stent implantation can trigger adverse thrombotic and coagulation responses.
  • Evaluating novel stent designs for improved hemocompatibility is crucial for patient outcomes.

Purpose of the Study:

  • To assess the impact of heparin coating on a new stent graft construction.
  • To evaluate the effect on platelet activation and coagulation parameters.

Main Methods:

  • Stent grafts with ePTFE membranes were tested in Chandler loops using human blood.
  • Measurements included platelet count, thrombin-antithrombin complex (TAT), CD11b, C3a, and C5b-9.
  • Comparative analysis across five groups: unmodified stents, untreated stent grafts, and various heparin-coated configurations.

Related Experiment Videos

Main Results:

  • Unmodified stents and untreated stent grafts showed significant platelet and coagulation activation (increased TAT, CD11b).
  • Heparin-coated stent grafts with an ePTFE membrane demonstrated significantly reduced activation compared to controls.
  • Scanning electron microscopy confirmed minimal thrombotic material deposition on heparin-modified stent grafts.

Conclusions:

  • Unmodified stent materials induce substantial platelet and coagulation system activation.
  • Heparin-coated stent grafts exhibit markedly improved hemocompatibility.
  • This heparin modification offers a promising strategy to enhance the safety and efficacy of stent devices.